Project Number 3R21AG063029-01A1S1 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for PERK determines polarized targeting of growth factors in neurons Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 6. Autophagy, Endocytosis and Membrane Trafficking a. Proteostasis Researcher and Organization Principal Investigator GIDALEVITZ, TALI Principal Investigator First Name TALI Principal Investigator Last Name GIDALEVITZ Awardee Organization DREXEL UNIVERSITY Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-935: Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) FY Overall Cost $250,948 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official WISE, BRADLEY C
